
PMC:7600245 / 12841-13206
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T43 | 22-29 | Disease | denotes | Allergy | http://purl.obolibrary.org/obo/MONDO_0005271 |
T44 | 34-44 | Disease | denotes | Infectious | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T110 | 113-114 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T111 | 190-192 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
T112 | 253-254 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | b |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T116 | 136-146 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T117 | 147-152 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T118 | 232-237 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T119 | 256-266 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T120 | 325-330 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T121 | 354-359 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T3 | 22-29 | Phenotype | denotes | Allergy | http://purl.obolibrary.org/obo/HP_0012393 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T94 | 0-365 | Sentence | denotes | National Institute of Allergy and Infectious Diseases (NIAID) in hospitalized adults (n = 1063) indicated that: (a) the patients in the remdesivir group had shorter median time to recovery (11 days) than the patients in the placebo group (15 days) and (b) remdesivir may decrease the mortality rate from 11.6% in the placebo group to 8% in the treatment group [40]. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
298 | 120-128 | Species | denotes | patients | Tax:9606 |
299 | 208-216 | Species | denotes | patients | Tax:9606 |
307 | 136-146 | Chemical | denotes | remdesivir | MESH:C000606551 |
308 | 256-266 | Chemical | denotes | remdesivir | MESH:C000606551 |
324 | 22-29 | Disease | denotes | Allergy | MESH:D004342 |
325 | 34-53 | Disease | denotes | Infectious Diseases | MESH:D003141 |
326 | 284-293 | Disease | denotes | mortality | MESH:D003643 |